|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
21,170,000 |
Market
Cap: |
7.83(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.2102 - $1.1678 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile InVivo Therapeutics Holdings is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. Co.'s Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The Neuro-Spinal Scaffold implant is intended to provide support to the surrounding tissue after injury, minimize expansion of areas of necrosis, and provide a biomaterial substrate for the body's own healing/repair processes following injury. The Neuro-Spinal Scaffold is composed of poly lactic-co-glycolic acid and Poly-L-Lysine biocompatible and bioresorbable polymers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
330,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$123,030 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
2 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Reynolds Francis |
CEO, CFO |
|
2012-12-17 |
4 |
AS |
$1.60 |
$6,830 |
D/D |
(4,250) |
14,343,660 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-12-14 |
4 |
AS |
$1.60 |
$7,073 |
D/D |
(4,250) |
14,347,910 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-12-13 |
4 |
AS |
$1.60 |
$6,800 |
D/D |
(4,250) |
14,352,160 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-12-12 |
4 |
AS |
$1.61 |
$7,012 |
D/D |
(4,250) |
14,356,410 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-12-11 |
4 |
AS |
$1.67 |
$7,146 |
D/D |
(4,250) |
14,360,660 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-12-10 |
4 |
AS |
$1.66 |
$7,058 |
D/D |
(4,250) |
14,364,910 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-12-07 |
4 |
AS |
$1.67 |
$7,163 |
D/D |
(4,250) |
14,369,160 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-12-06 |
4 |
AS |
$1.65 |
$7,018 |
D/D |
(4,250) |
14,373,410 |
|
- |
|
Hess Brian |
CHIEF SCIENCE OFFICEROfficer |
|
2012-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,100 |
|
- |
|
Langer Robert |
10% Owner |
|
2012-07-02 |
4 |
S |
$2.39 |
$48,265 |
D/D |
(20,220) |
7,697,113 |
|
- |
|
Langer Robert |
10% Owner |
|
2012-06-29 |
4 |
S |
$2.31 |
$57,167 |
D/D |
(24,780) |
7,717,333 |
|
- |
|
Langer Robert |
10% Owner |
|
2012-06-28 |
4 |
S |
$2.30 |
$34,560 |
D/D |
(15,000) |
7,742,113 |
|
- |
|
Langer Robert |
10% Owner |
|
2012-06-27 |
4 |
S |
$2.40 |
$32,280 |
D/D |
(13,450) |
7,757,113 |
|
- |
|
Langer Robert |
10% Owner |
|
2012-06-26 |
4 |
S |
$2.42 |
$306,251 |
D/D |
(126,550) |
7,770,563 |
|
- |
|
Langer Robert |
10% Owner |
|
2012-04-16 |
4 |
S |
$2.40 |
$383,616 |
D/D |
(159,840) |
7,897,113 |
|
- |
|
Langer Robert |
10% Owner |
|
2012-04-13 |
4 |
S |
$2.39 |
$95,982 |
D/D |
(40,160) |
8,056,953 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-01-06 |
4 |
S |
$2.53 |
$244,375 |
D/D |
(96,503) |
14,647,660 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-01-05 |
4 |
S |
$2.63 |
$286,779 |
D/D |
(109,000) |
14,744,163 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2012-01-04 |
4 |
S |
$2.62 |
$116,791 |
D/D |
(44,497) |
14,853,163 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2011-12-28 |
4 |
S |
$2.74 |
$392,645 |
D/D |
(143,500) |
15,004,160 |
|
- |
|
Reynolds Francis |
CEO, CFO |
|
2011-11-29 |
4 |
S |
$2.52 |
$239,020 |
D/D |
(95,000) |
14,909,160 |
|
- |
|
Reynolds Francis |
Chief Executive OfficerOfficer |
|
2010-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,147,660 |
|
- |
|
Langer Robert |
10% Owner |
|
2010-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,262,360 |
|
- |
|
Nolen George |
Director |
|
2010-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
Pedra Christi |
Director |
|
2010-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
458 Records found
|
|
Page 18 of 19 |
|
|